about
The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics.Daclizumab treatment for multiple sclerosis.Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside alleviates neurodegeneration in experimental autoimmune encephalomyelitisInterferon beta and glatiramer acetate therapy.Combination therapy of lovastatin and rolipram provides neuroprotection and promotes neurorepair in inflammatory demyelination model of multiple sclerosis.Update on the treatment options for multiple sclerosis.
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Combination therapy in multiple sclerosis.
@ast
Combination therapy in multiple sclerosis.
@en
type
label
Combination therapy in multiple sclerosis.
@ast
Combination therapy in multiple sclerosis.
@en
prefLabel
Combination therapy in multiple sclerosis.
@ast
Combination therapy in multiple sclerosis.
@en
P2860
P1476
Combination therapy in multiple sclerosis.
@en
P2093
Fred D Lublin
Mark J Tullman
P2860
P2888
P304
P356
10.1007/S11910-005-0053-9
P577
2005-05-01T00:00:00Z